Xcout Intel
Promontory Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Promontory Therapeutics among drug discovery companies — ranked by similarity to what Promontory Therapeutics actually does, not by market-cap band.
Subscribe to see Promontory Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Promontory Therapeutics
Promontory Therapeutics Inc. is a privately held, clinical-stage pharmaceutical company founded in 2010 and headquartered in New York, NY. The firm focuses on small molecule immunotherapy.
Promontory Therapeutics at a glance
Promontory Therapeutics is a drug discovery company headquartered in United States. Its most recent funding round, Series A, raised $37M in December 2021. Xcout tracks 7 named people at Promontory Therapeutics, including Johan Baeck (EXECUTIVE VICE PRESIDENT & CMO).
Promontory Therapeutics leadership
- Johan BaeckEXECUTIVE VICE PRESIDENT & CMO
- Robert E. FallonPRESIDENT & CEO
- R. Matthew PriceEXECUTIVE VICE PRESIDENT & COO
- Tyler AmesSVP, RESEARCH & DEVELOPMENT
- Hélène A. SheaVP, CHEMISTRY MANUFACTURING & CONTROLS
- Aamena ChaudhryDIRECTOR, REGULATORY AFFAIRS
1 more named person on record for Promontory Therapeutics, with roles, board committees and tenure — see the full roster →
Promontory Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $37M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Promontory Therapeutics competitors
Ranked by semantic similarity — how close each company is to Promontory Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar drug discovery company
Peptomyc is a clinical-stage biotechnology company headquartered in Barcelona, Spain, specializing in the development of protein and peptide therapeutics for cancer.
Similar drug discovery company
KayoThera, Inc. is an early-stage, preclinical therapeutics company headquartered in Seattle, Washington. The firm focuses on developing first-in-class, oral, small molecule treatments.
Similar drug discovery company
Ahammune Biosciences is an India-based drug-discovery biotechnology company focused on developing small-molecule therapies for immune-mediated and inflammatory diseases. It serves pharmaceutical and healthcare markets by advancing novel immunomodulatory drug candidates toward clinical development.
Similar drug discovery company
COUR Pharmaceuticals is a clinical-stage biotechnology company headquartered in Evanston, Illinois, founded in 2015. The firm focuses on reprogramming the immune system to develop novel treatments for autoimmune diseases.
Similar drug discovery company
Bridge Medicines LLC is a drug discovery holding company headquartered in New York, NY, that accelerates the path of therapeutic pipelines from research to patients.
Similar drug discovery company
Ensho Therapeutics, Inc. is a privately held, clinical-stage biopharmaceutical company focused on developing breakthrough oral therapies for patients. Founded in 2024, the company is based in Morris Plains, New Jersey.
Biopharma
Arch Oncology is a clinical-stage immuno-oncology company headquartered in Brisbane, California, with an additional scientific research laboratory in St. Louis, Missouri. The company develops antibody-based cancer therapies.
Similar drug discovery company
Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company headquartered in South San Francisco, California. It specializes in developing novel T-cell engaging therapies for the treatment of cancer.
Similar drug discovery company
Momotaro-Gene Inc. is a drug discovery company established in 2007 and headquartered in Okayama, Japan. The company focuses on pharmaceutical research and the development of next-generation cancer therapeutics.
Similar drug discovery company
NXI Therapeutics AG is a biotech company based in Basel, Switzerland, focused on researching and developing selective immunosuppressive drugs and immunotherapies for autoimmune diseases and transplantation.
Similar drug discovery company
PAQ Therapeutics is a clinical-stage biotechnology company that utilizes autophagy to develop small-molecule KRAS degraders for the treatment of lethal cancers. The company's research focuses on restoring health and curing diseases that currently lack effective treatment options.
Similar drug discovery company
Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in Boston, Massachusetts. The company discovers and develops Anticalin-based drugs designed to address significant medical needs.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Promontory Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Promontory Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →